A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
Clinical trial NCT03971422 · COMPLETED
Trial details
- NCT number
- NCT03971422
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-03
- Primary completion
- 2021-08-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.